Description
PharmaQo Anavar 50 delivers 50 mg Oxandrolone per oral tablet, supplied in 60-tablet packs for research use. Oxandrolone is under investigation for its anabolic potential, effects on nitrogen retention, muscle preservation in catabolic states, and bone density support.
Due to its mild androgenic profile and low hepatotoxicity at research doses, Oxandrolone is frequently used in sensitive investigational models.
Product Details:
Active Ingredient:
-
Oxandrolone (Anavar)
Concentration: 50 mg per tablet
Form: Oral tablets
Packaging: 60 tablets per pack
Pharmacokinetics:
Oxandrolone has an oral half-life of ~9 hours, supporting once or twice daily administration in research protocols.
Usage Recommendations:
-
Indications (Research Context): Investigational use in muscle-wasting models, nitrogen retention studies, bone density research (not approved for human use)
-
Typical Dosage (Research Use): 25–100 mg per day, depending on research design
-
Monitoring: Lipid profile, liver enzymes, cardiovascular health, androgenic markers
-
Cycle/Duration: 4–8 weeks, per research protocol
Disclaimer:
This product is intended strictly for research and educational purposes. It is not for human consumption or therapeutic use. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with medical conditions. Always comply with local research laws and ethical standards.